Family: | Principal Financial Services |
Name: | Principal Healthcare Innovators ETF |
Inception Date: | 19-Aug-2016 |
Termination Date: | |
Investment Objective: | The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable. |
Prospectus | |
Top 10 Holdings | ||
EXACT SCIENCES CORP COMMON STOCK USD.01 | EXAS | 2.9022% |
SAREPTA THERAPEUTICS INC COMMON STOCK USD.0001 | SRPT | 2.8205% |
NATERA INC COMMON STOCK | NTRA | 2.5926% |
ALNYLAM PHARMACEUTICALS INC COMMON STOCK USD.01 | ALNY | 2.5269% |
BIO RAD LABORATORIES A COMMON STOCK USD.0001 | BIO | 2.4678% |
ILLUMINA INC COMMON STOCK USD.01 | ILMN | 2.0450% |
ELANCO ANIMAL HEALTH INC COMMON STOCK | ELAN | 2.0069% |
CYTOKINETICS INC COMMON STOCK USD.001 | CYTK | 1.7688% |
CEREVEL THERAPEUTICS HOLDING COMMON STOCK USD.0001 | CERE | 1.7178% |
Top 10 Holdings Weight: | 22.5% |
Number of Holdings: | 219 |
Shares Outstanding: | 1,170,001 |
Total Net Assets: | 44,495,140 |
NAV: | 38.09 |
Net Expense Ratio: | 0.42% |
Asset Class: | Equities (Stocks) |
Developed or Emerging: | Developed Market Funds |
Country: | US |
Region: | |
Strategy: | |
Currency: | |
Commodity: | |
Sector: | Healthcare |
Industry: | |
Dividend Type: | |
Tax Exempt State: | |
Maturity Duration: | |
Market Cap: | Broad Market / Multi-Cap |
Credit Quality: | |
Mortgage Bond Types: | |
Bond Type: | |
Gov't Bond Types: | |
Reit Type: | |
Leverage Direction/Factor: | |
Is Currency Hedged: | No |
US or Ex-US: | Domestic |